| |
| |
|
| Insider
Information: |
Bishop John E |
| Relationship: |
SVP, Chief Technology ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
157,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,252,637 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,253 |
|
|
| Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-07-23 |
4 |
AS |
$20.77 |
$1,411,206 |
D/D |
(67,950) |
49,549 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
167,086 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
SVP, Chief Technology Officer |
• – – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,950) |
0 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2011-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
99,642 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-18 |
4 |
AS |
$23.00 |
$838,067 |
D/D |
(35,529) |
99,380 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-05-11 |
4 |
OE |
$15.37 |
$528,591 |
D/D |
33,625 |
137,610 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-05-11 |
4 |
AS |
$20.70 |
$696,038 |
D/D |
(33,625) |
111,485 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2008-08-06 |
4 |
AS |
$18.00 |
$513,000 |
D/D |
(28,500) |
38,550 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-01-09 |
4 |
AS |
$19.50 |
$529,601 |
D/D |
(27,159) |
93,780 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
SVP, Chief Technology Officer |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
25,950 |
47,950 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-18 |
4 |
OE |
$12.58 |
$315,078 |
D/D |
24,529 |
119,943 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Chief Technology Officer |
• – – |
2021-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
VP Pharma Sciences & Manufact |
• – – |
2006-02-17 |
4 |
OE |
$8.10 |
$177,188 |
D/D |
21,875 |
21,875 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
VP Pharma Sciences & Manufact |
• – – |
2006-02-17 |
4 |
S |
$24.42 |
$539,292 |
D/D |
(21,875) |
0 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-19 |
4 |
AS |
$25.50 |
$542,487 |
D/D |
(21,274) |
99,380 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-19 |
4 |
OE |
$15.44 |
$328,471 |
D/D |
21,274 |
118,100 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,312 |
113,092 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
18,862 |
127,367 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2010-01-25 |
4 |
AS |
$14.98 |
$261,895 |
D/D |
(17,483) |
42,100 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
110,620 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2006-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2007-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
30,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2013-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
102,166 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2008-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,800 |
39,300 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,473 |
106,155 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
